The Institute for Clinical and Translational Science (ICTS) at the University of Iowa (UI) was established by the Board of Regents to realize three objectives - first, to lead the development of translational science at the UI; second, to advance translational science as a distinct academic discipline; and third, to disseminate capacities in translational science across the State of Iowa. This mandate enabled us to tackle large problems affecting translational science that required institutional solutions, such as transforming regulatory processes for human subjects research, developing an informatics infrastructure for integrating electronic medical record and other health care data, establishing bi-directional relationships with community organizations, and revitalizing the pipeline of well-trained clinical and translational researchers. The task for this new application is extend our impact and to build a model learning health system (LHS) to integrate research and practice across the lifespan and across the T0 - T4 translational spectrum with the intent of accelerating the translation of discovery to improved population health. Becoming an exemplary next generation CTSA that can produce logarithmic acceleration requires refocusing many current programs and creating new resources to: (1) promote workforce development; (2) systematically engage stakeholders; (3) integrate translational research along several distinct dimensions; and (4) spur innovation. The milestones for this application have a special focus on rural health, community engagement, research- practice integration, clinical research efficiency, innovative statistical methods, and rare genetic diseases. In addition, some of the milestones reflect our interest in working with other CTSA hubs to empirically test different approaches and for developing an evidence base of proven strategies for accelerating translation that can be more broadly disseminated. In this way we can incentivize the development and adoption of new methods and promote innovation in everyday research processes throughout Iowa and beyond our borders. In particular, we will engage investigators and stakeholders across Iowa using approaches that overcome the geographic barriers in a rural state and that build on our established community practice networks of family physicians, clinics, school nurses and pharmacists, with particular examples related to lifespan research and child abuse. To build this LHS we will engage and train undergraduates, pre and postdoctoral trainees, established investigators research staff and clinicians at the UI and in the newly formed UI Health Alliance (an integrated network of 58 hospitals, 175 clinics, critical access hospitals in rural communities regional medical centers, and the UI) which touches 60% of the population in Iowa to drive clinical and translational discovery and to change healthcare practice in a variety of clinical settings.

Public Health Relevance

The mission of the University of Iowa Institute for Clinical and Translational Science (ICTS) is to accelerate translational science through programs to develop the translational science workforce, to promote the engagement of community members and other stakeholder, to promote research integration across the lifespan, and to catalyze innovative clinical and translational research. These efforts will lead t the development of novel therapies and healthcare delivery strategies, the integration of translational research and clinical practice and, ultimately, to measurable improvements in the health of Iowa and the nation.

Agency
National Institute of Health (NIH)
Institute
National Center for Advancing Translational Sciences (NCATS)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
1U54TR001356-01
Application #
8995815
Study Section
Special Emphasis Panel (ZTR1-CI-8 (01))
Program Officer
Davis Nagel, Joan
Project Start
2015-08-14
Project End
2017-07-31
Budget Start
2015-08-14
Budget End
2016-07-31
Support Year
1
Fiscal Year
2015
Total Cost
$3,528,613
Indirect Cost
$1,193,716
Name
University of Iowa
Department
Type
Organized Research Units
DUNS #
062761671
City
Iowa City
State
IA
Country
United States
Zip Code
52246
Bock, Joshua M; Treichler, David P; Norton, Samuel L et al. (2018) Inorganic nitrate supplementation enhances functional capacity and lower-limb microvascular reactivity in patients with peripheral artery disease. Nitric Oxide 80:45-51
Gehlbach, Brian K; Sainju, Rup K; Tadlock, Deanne K et al. (2018) Tolerability of a comprehensive cardiorespiratory monitoring protocol in an epilepsy monitoring unit. Epilepsy Behav 85:173-176
Tong, Brian; Abosi, Oluchi; Schmitz, Samantha et al. (2018) Bipolar disorder and related mood states are not associated with endothelial function of small arteries in adults without heart disease. Gen Hosp Psychiatry 51:36-40
Gourronc, Francoise A; Robertson, Larry W; Klingelhutz, Aloysius J (2018) A delayed proinflammatory response of human preadipocytes to PCB126 is dependent on the aryl hydrocarbon receptor. Environ Sci Pollut Res Int 25:16481-16492
Crawford, Kathryn J; Barnes, Lindsey A; Peters, Thomas M et al. (2018) Identifying determinants of noise in a medical intensive care unit. J Occup Environ Hyg :1-21
DuBose, Lyndsey E; Boles Ponto, Laura L; Moser, David J et al. (2018) Higher Aortic Stiffness Is Associated With Lower Global Cerebrovascular Reserve Among Older Humans. Hypertension 72:476-482
Baquero, Barbara; Kava, Christine M; Ashida, Sato et al. (2018) Active Ottumwa: Adapting Evidence-Based Recommendations to Promote Physical Activity in a Micropolitan New Destination Community. Int J Environ Res Public Health 15:
Davies, Jane C; Moskowitz, Samuel M; Brown, Cynthia et al. (2018) VX-659-Tezacaftor-Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles. N Engl J Med 379:1599-1611
Keating, Dominic; Marigowda, Gautham; Burr, Lucy et al. (2018) VX-445-Tezacaftor-Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles. N Engl J Med 379:1612-1620
Gehlbach, Brian K; Patel, Shruti B; Van Cauter, Eve et al. (2018) The Effects of Timed Light Exposure in Critically Ill Patients: A Randomized Controlled Pilot Clinical Trial. Am J Respir Crit Care Med 198:275-278

Showing the most recent 10 out of 72 publications